OSUCCC-James Cancer Hospital and Solove Research Institute

At the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), our vision is to create a cancer-free world, one person, one discovery at a time. This underlies everything we do in working to eradicate cancer through research that translates to innovative and highly targeted patient care.

The OSUCCC – James is the only cancer program in the country that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nation’s largest public universities.

At the Forefront of Research

The OSUCCC – James is one of only 41 comprehensive cancer centers in the nation as designated by the NCI, a designation that we have maintained through competitive renewal since 1976. After the site review for our most recent renewal, we earned the NCI’s highest ranking, “exceptional,” and received a five-year, $23 million NCI support grant. The NCI survey team stated that the OSUCCC – James “should serve as the model for other matrix university-based centers.”

At Ohio State, more than 300 world-renowned cancer researchers from 12 of 14 colleges and their teams work collaboratively, across multiple disciplines, to understand the molecular and genetic mechanisms of cancer and to improve cancer treatment, care and prevention.

Ohio State’s Comprehensive Cancer Center has:

• Distinction as one of only four cancer centers in the nation funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs

• Charter membership in the National Comprehensive Cancer Network, an alliance of 21 leading cancer centers that establishes national clinical oncology practice guidelines and standards of cancer care used nationwide

• A record of consistently recruiting the world’s leading cancer researchers, whose groundbreaking work has helped Ohio State’s NCI grant funding quadruple over the past decade, making us the nation’s 15th highest NCI-funded cancer program

• A robust clinical trials program that involves the participation of 1 out of every 4 patients diagnosed and treated at the OSUCCC – James and includes an online cancer clinical trials search tool (go.osu.edu/cancerclinicaltrials)

• The Total Cancer Care® Program, a medical information and biorepository research protocol that involves an innovative lifetime partnership with patients through universal consenting

• A set of 20 Shared Resources that provide investigators with ready access to specialized technologies, services, methodologies and consultations that enhance their ability to conduct cancer research (go.osu.edu/sharedresources)

• A unique Drug Development Institute that was created to accelerate cancer drug discovery and development at Ohio State through collaboration and results-based project management and speed new cancer treatments to patients

Excellence in Cancer Care

In 1990, Ohio State opened The James, the Midwest’s first freestanding cancer hospital, as the patient-care component of the OSUCCC. Ranked by U.S.News and World Report as one of the top hospitals in the nation for cancer care, The James is one of only 11 DRG- or PPS-exempt institutions in the United States.

At Ohio State, we’ve helped pioneer the transdisciplinary, multimodality approach to cancer treatment and patient care. As a founding member of the National Comprehensive Cancer Network, we help establish national guidelines and standards of cancer care.

The OSUCCC – James has more than 200 oncologists, all of whom specialize in just one type of cancer, and it’s that sub-specialization and expertise that helps lead to more productive integration with cancer research and, ultimately, to better outcomes. We manage hundreds of active or pending cancer trials, many of which are initiated by OSUCCC – James investigators. Our genetic- and molecular-based research helps us understand each patient’s unique cancer and develop and deliver the targeted therapy that leads to better outcomes, fewer side effects and more hope.

Our disease-site groups combine the expertise of surgical oncologists, medical oncologists, pathologists, radiologists, radiation oncologists, nurses, researchers and others to collaborate to provide patients with the latest in cancer detection, diagnosis, treatment and prevention. Patients are cared for by a team of experts who tailor a targeted treatment plan for their individual cancer.

The James also includes:

• 228 patient beds, including a 24-bed blood and marrow transplant (BMT) unit

• intraoperative radiation therapy

• special isolation rooms

• chemotherapy and special transfusion areas

• specialized diagnostic equipment

• a nine-bed clinical trials unit for early-phase investigational drug delivery

• outpatient facilities located on campus and across central Ohio

• the Stefanie Spielman Comprehensive Breast Center, which is an American College of Radiology Breast Imaging Center of Excellence and the only facility of its kind in the Midwest to offer the full spectrum of breast cancer care – from prevention and screening through detection, diagnosis, treatment and survivorship – in one world-class facility; and

• a network of community hospital affiliations to help us provide the latest and most effective cancer preventions, treatments and cures throughout the Midwest.

A model of excellence in patient care, the OSUCCC – James has achieved Magnet® designation as part of the American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program®. This voluntary hospital recognition program is considered the highest honor an organization can receive for quality patient care and professional nursing practice. In addition, the OSUCCC – James is designated as a “top hospital” by the Leapfrog Group, a national coalition of public and private purchasers of employee health coverage who collectively work to improve healthcare quality. The OSUCCC – James is fully accredited by the Joint Commission, the American College of Surgeons’ Commission on Cancer, and the Foundation for the Accreditation of Cellular Therapy.

The New James: The 21st Century Cancer Hospital

In December 2014, Ohio State will open the doors of the new James Cancer Hospital and Solove Research Institute, a transformational facility that fosters collaboration and integration of research and clinical cancer care. This new 21-floor hospital will help revolutionize the way cancer prevention and care are provided in this nation, with world-class oncologists and cancer researchers working side-by-side to unlock the mysteries of why we get cancer and, using those discoveries, move from treating cancer to preventing it from ever occurring.

The patients served by the new hospital will find themselves at the intersection of research, education and sub-specialized care. Research and education spaces will be located on every floor, enhancing our bench-to-beside approach to patient care and giving patients early access to new treatments and tools.

Cancer is no longer defined solely by stage and location, but rather by its biologic and genetic make-up. There is no routine cancer – it is different in each person. Working together and utilizing state-of-the-art facilities and technology, clinicians and researchers at Ohio State are at the forefront of speeding the development and delivery of treatments that target the molecules and markers fueling each person’s unique cancer..

For more information about how the OSUCCC – James is creating a cancer-free world, please visit our website at cancer.osu.edu.

Map & Directions: